GRAL

GRAIL, Inc. GRAL

$72.62 +0.66 (+0.92%)

Neutral · +0.81σ

+ Compare Open in Sniper

Mkt cap $3.2B

P/E —

Day $69.69 – $72.75

52wk $41.50 – $118.84

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

GRAIL, Inc. is a healthcare company listed in the US.

GRAL last traded at $72.62, up 0.9% on the day; that's in the middle part of its 52-week range ($41.50–$118.84). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Fair-value range

$10.29 – $10.29

Verdict

Unknown

Accounting quality Weak

✓ More cash than debt
✓ Quick ratio 10.56 (antifragile)
✓ Current ratio 11.97 (antifragile)
✓ Debt/equity 0.13 (antifragile)

⚠ Intangibles 63% of assets (fragile asset base)
⚠ Negative retained earnings
⚠ Stock comp 40% of revenue (heavy dilution)

Key statistics

All statistics →

GRAL is a $3.2 billion company.

Mkt cap $3.2B

P/E ttm —

Fwd P/E —

Beta —

Day range $69.69 – $72.75

52w range $41.50 – $118.84

Avg vol —

RSI(2) 48.1

ROE —

Net mgn —

FCF mgn -73.2%

Debt/Eq 2.04

Div yld —

Sector Healthcare

Industry Diagnostics & Research

Next earn —

52-week range · today's price

$41.50$118.84